BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20304627)

  • 1. Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG).
    Mackay HJ; Gallinger S; Tsao MS; McLachlin CM; Tu D; Keiser K; Eisenhauer EA; Oza AM
    Eur J Cancer; 2010 May; 46(8):1365-73. PubMed ID: 20304627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.
    Zighelboim I; Goodfellow PJ; Gao F; Gibb RK; Powell MA; Rader JS; Mutch DG
    J Clin Oncol; 2007 May; 25(15):2042-8. PubMed ID: 17513808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
    Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between microsatellite instability and PTEN gene mutations in endometrial cancer.
    Bilbao C; Rodríguez G; Ramírez R; Falcón O; León L; Chirino R; Rivero JF; Falcón O; Díaz-Chico BN; Díaz-Chico JC; Perucho M
    Int J Cancer; 2006 Aug; 119(3):563-70. PubMed ID: 16506206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for different expression profiles for c-Met, EGFR, PTEN and the mTOR pathway in low and high grade endometrial carcinomas in a cohort of consecutive women. Occurrence of PIK3CA and K-Ras mutations and microsatellite instability.
    Thoury A; Descatoire V; Kotelevets L; Kannengiesser C; Bertrand G; Theou-Anton N; Frey C; Genestie C; Raymond E; Chastre E; Lehy T; Walker F
    Histol Histopathol; 2014 Nov; 29(11):1455-66. PubMed ID: 24811063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
    Nout RA; Bosse T; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; van Eijk R; Ter Haar NT; Smit VT
    Gynecol Oncol; 2012 Sep; 126(3):466-73. PubMed ID: 22609107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcome.
    Peiró G; Lohse P; Mayr D; Diebold J
    Am J Clin Pathol; 2003 Jul; 120(1):78-85. PubMed ID: 12866376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.
    Moroney MR; Davies KD; Wilberger AC; Sheeder J; Post MD; Berning AA; Fisher C; Lefkowits C; Guntupalli SR; Behbakht K; Corr BR
    Gynecol Oncol; 2019 Jun; 153(3):517-520. PubMed ID: 30910249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: implications for pathogenetic and survival differences.
    Mao TL; Ayhan A; Kuo KT; Lin MC; Tseng LH; Ogawa H
    Histopathology; 2015 Oct; 67(4):474-82. PubMed ID: 25648330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
    Baldinu P; Cossu A; Manca A; Satta MP; Pisano M; Casula M; Dessole S; Pintus A; Tanda F; Palmieri G
    Cancer; 2002 Jun; 94(12):3157-68. PubMed ID: 12115348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.
    Arabi H; Guan H; Kumar S; Cote M; Bandyopadhyay S; Bryant C; Shah J; Abdul-Karim FW; Munkarah AR; Ali-Fehmi R
    Gynecol Oncol; 2009 May; 113(2):153-8. PubMed ID: 19275958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.
    Zighelboim I; Schmidt AP; Gao F; Thaker PH; Powell MA; Rader JS; Gibb RK; Mutch DG; Goodfellow PJ
    J Clin Oncol; 2009 Jul; 27(19):3091-6. PubMed ID: 19470935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of microsatellite instability on survival of endometrial cancer patients.
    Kanopienė D; Smailytė G; Vidugirienė J; Bacher J
    Medicina (Kaunas); 2014; 50(4):216-21. PubMed ID: 25458958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable survival associated with microsatellite instability in endometrioid endometrial cancers.
    Maxwell GL; Risinger JI; Alvarez AA; Barrett JC; Berchuck A
    Obstet Gynecol; 2001 Mar; 97(3):417-22. PubMed ID: 11239648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
    Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
    Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
    Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
    Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.